FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:449-450 August 8, 2002 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Cines, D. B. PubMed Citation

To the Editor: We were disappointed that the use of pulsed high-dose dexamethasone in patients with chronic, refractory immune thrombocytopenic purpura was not mentioned in the review article on this condition by Cines and Blanchette (March 28 issue).¹ We have treated three adults who had relapses of immune thrombocytopenic purpura after splenectomy with six cycles of pulsed high-dose dexamethasone, and two of these patients had complete remission lasting for as long as four years of follow-up (Table 1). Warner et al.² refuted the claim that pulsed high-dose dexamethasone has a role in treating chronic immune thrombocytopenic purpura; they . . . [Full Text of this Article]

This article has been cited by other articles:

• Cheng, Y., Wong, R. S.M., Soo, Y. O.Y., Chui, C. H., Lau, F. Y., Chan, N. P.H., Wong, W. S., Cheng, G. (2003). Initial Treatment of Immune Thrombocytopenic Purpura with High-Dose Dexamethasone. NEJM 349: 831-836 [Abstract] [Full Text]